Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Dow
Johnson and Johnson
Merck
AstraZeneca

Last Updated: June 25, 2022

Smithkline Beecham Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SMITHKLINE BEECHAM, and what generic and branded alternatives to SMITHKLINE BEECHAM drugs are available?

SMITHKLINE BEECHAM has three approved drugs.



Summary for Smithkline Beecham
US Patents:0
Tradenames:3
Ingredients:3
NDAs:3
Drug Master File Entries: 2

Drugs and US Patents for Smithkline Beecham

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 DISCN No No See Plans and Pricing See Plans and Pricing
Smithkline Beecham RELAFEN nabumetone TABLET;ORAL 019583-001 Dec 24, 1991 DISCN Yes No See Plans and Pricing See Plans and Pricing
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-001 Dec 20, 1990 DISCN Yes No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Smithkline Beecham

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 4,375,547 See Plans and Pricing
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 4,760,075 See Plans and Pricing
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-001 Dec 20, 1990 4,466,972 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for SMITHKLINE BEECHAM drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Oral Solution 15 mg/mL ➤ Subscribe 2008-05-14
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Boehringer Ingelheim
Baxter
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.